Enhanced Large Intestinal Potassium Permeability in End-stage Renal Disease
Affiliations
The capacity of the colon for potassium (K+) secretion increases in end-stage renal disease (ESRD), to the extent that it makes a substantial contribution to K+ homeostasis. This colonic K+ adaptive response may reflect enhanced active K+ secretion, and be associated with an increase in apical membrane K+ permeability. In this study, this hypothesis was tested in patients with normal renal function or ESRD, by evaluating the effect of barium ions (a K+ channel inhibitor) on rectal K+ secretion using a rectal dialysis technique, and the expression of high conductance (BK) K+ channel protein in colonic mucosa by immunohistochemistry. Under basal conditions, rectal K+ secretion was almost threefold greater (p < 0.02) in ESRD patients (n = 8) than in patients with normal renal function (n = 10). Intraluminal barium (5 mmol/l) decreased K+ secretion in the ESRD patients by 45% (p < 0.05), but had no effect on K+ transport in patients with normal renal function. Immunostaining using a specific antibody to the BK channel alpha-subunit revealed greater (p < 0.001) levels of BK channel protein expression in surface colonocytes and crypt cells in ESRD patients (n = 9) than in patients with normal renal function (n = 9), in whom low levels of expression were mainly restricted to surface colonocytes. In conclusion, these results suggest that enhanced colonic K+ secretion in ESRD involves an increase in the apical K+ permeability of the large intestinal epithelium, which most likely reflects increased expression of apical BK channels.
Aldosterone and Potassium in Heart Failure: Overcoming This Major Impediment in Clinical Practice.
Khan L, Jamil A, Greene S, Khan M, Butler J Card Fail Rev. 2025; 10:e18.
PMID: 39872850 PMC: 11770538. DOI: 10.15420/cfr.2024.09.
Bai Z, Lu G, Yang H, Zhang D, Zhang Y, Sun Z Ren Fail. 2024; 46(2):2359640.
PMID: 38832483 PMC: 11151801. DOI: 10.1080/0886022X.2024.2359640.
New Insights Into Dietary Approaches to Potassium Management in Chronic Kidney Disease.
Sumida K, Biruete A, Kistler B, Khor B, Ebrahim Z, Giannini R J Ren Nutr. 2023; 33(6S):S6-S12.
PMID: 37610407 PMC: 10872890. DOI: 10.1053/j.jrn.2022.12.003.
Nickerson A, Rajendran V Cell Mol Life Sci. 2023; 80(8):209.
PMID: 37458846 PMC: 11073443. DOI: 10.1007/s00018-023-04857-x.
Managing Hyperkalemia in the Modern Era: A Case-Based Approach.
Massicotte-Azarniouch D, Canney M, Sood M, Hundemer G Kidney Int Rep. 2023; 8(7):1290-1300.
PMID: 37441466 PMC: 10334407. DOI: 10.1016/j.ekir.2023.04.016.